The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.
The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.
France Halts Brazil Flights; NYC Reschedules Shots: Virus Update Bloomberg 17 mins ago Bloomberg News
(Bloomberg) The U.S. expects to have enough coronavirus vaccine to meet U.S. demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.
German Chancellor Angela Merkel’s cabinet approved a law setting nationwide rules on virus restrictions after some regions failed to impose curbs despite rising cases. Italy is in talks to set up vaccine production hubs as the government seeks to build domestic capacity. Meanwhile, the U.K. hit a goal to offer a shot to all over 50s three days early.
The U.S. expects to have enough vaccine to meet demand by May despite a planned pause in the use of Johnson & Johnson’s shot pending a review of rare blood clots. J&J said it’s delaying its rollout in Europe.
Pfizer Ramps Up Production; Moderna Effectiveness: Virus Update msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.